
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 1204310-73-5 | 货号 | BCP49214 |
中文名 | WP1122 | ||
英文名 | WP1122 | ||
中文别名 | |||
英文别名 | WP-1122;WP 1122; | ||
SMILES | CC(=O)OCC1C(C(CC(O1)O)OC(=O)C)O | ||
化学名称 | |||
分子式 | C10H16O7 | 分子量 | 248.23 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | WP-1122(WP 1122) is a candidate drug to treat SARS-COV-2(COVID-19) .2-DG completely prevented SARS-CoV–2 replication in Caco–2 cells. Glycolysis is a process by which cells convert glucose into energy and infected (host) cells are induced by viruses to dramatically increase their dependence on glycolysis. WP1122 is a prodrug of 2-DG whereby chemical elements are added to 2-DG to improve its delivery in vivo. |
相关产品推荐
查看更多 >Tags:WP1122 供应商,WP1122 购买,WP1122 生产,WP1122 批量,WP1122 供应,WP1122 订购,WP1122 采购